Pretransplant cardiac stress testing and transplant wait time in kidney transplantation candidates.


Journal

Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219

Informations de publication

Date de publication:
13 Sep 2024
Historique:
received: 05 05 2024
accepted: 04 09 2024
medline: 15 9 2024
pubmed: 15 9 2024
entrez: 14 9 2024
Statut: epublish

Résumé

Routine screening for cardiovascular disease before kidney transplantation remains controversial. This study aims to compare cardiac testing rates in patients with end-stage renal disease, referred and not referred for transplantation, and assess the impact of testing on transplant wait times. This is a retrospective cohort study of 22 687 end-stage renal disease patients from 2011 to 2022, within an integrated health system. Cardiac testing patterns, and the association between cardiac testing and transplant wait times and post-transplant mortality were evaluated. Of 22 687 patients (median age 66 years, 41.1% female), 6.9% received kidney transplants, and 21.0% underwent evaluation. Compared with dialysis patients, transplant patients had a 5.6 times higher rate of stress nuclear myocardial perfusion imaging with single-photon emission (rate ratio (RR) 5.64, 95% CI 5.37 to 5.92), a 6.5 times higher rate of stress echocardiogram (RR 6.51, 95% CI 5.65 to 7.51) and 16% higher cardiac catheterisation (RR 1.16, 95% CI 1.06 to 1.27). In contrast, revascularisation rates were significantly lower in transplant patients (RR 0.46, 95% CI 0.36 to 0.58). Transplant wait times were longer for patients who underwent stress testing (median 474 days with no testing vs 1053 days with testing) and revascularisation (1796 days for percutaneous intervention and 2164 days for coronary artery bypass surgery). No significant association was observed with 1-year post-transplant mortality (adjusted OR 1.99, 95% CI 0.46 to 8.56). This study found a higher rate of cardiac testing in dialysis patients evaluated for kidney transplants. Cardiac testing was associated with longer transplant wait time, but no association was observed between testing and post-transplant mortality.

Identifiants

pubmed: 39277185
pii: openhrt-2024-002738
doi: 10.1136/openhrt-2024-002738
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Ming-Sum Lee (MS)

Department of Cardiology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA mingsum.lee@kp.org.

Columbus Batiste (C)

Department of Cardiology, Kaiser Permanente Riverside Medical Center, Riverside, California, USA.

James Onwuzurike (J)

Department of Cardiology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA.

Rachid Elkoustaf (R)

Department of Cardiology, Kaiser Permanente Riverside Medical Center, Riverside, California, USA.

Yi-Lin Wu (YL)

Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.

Wansu Chen (W)

Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.

Joseph Kahwaji (J)

Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA.

Amandeep Sahota (A)

Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA.

Roland L Lee (RL)

Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH